Luminist Labs
AcquiredDiagnostic platform for early detection of liver disease
What it does
Luminist developed a non-invasive diagnostic test for the early detection and staging of liver fibrosis and non-alcoholic steatohepatitis (NASH). Luminist was acquired in 2020 by DiscernDx.
Next to it in Healthcare and bio · non-invasive liver disease diagnostics
- Kenota (formerly ExVivo Labs)Y Combinator S16
Kenota is revolutionizing the way we test for disease
- ACCELStars, Inc.Plug and Play
The University of Tokyo Medical! Sleep with the world's highest accuracy with arm-mounted equipment-Captures awakening, and discover, treat, and prevent brain and mental illness. / 東大医発!腕装着機器で世界最高精度の技術で睡眠-覚醒を捉え、脳と心の病気等を早期発見・治療・予防する
- HA-PPY Co., LtdPlug and Play
Provision of devices and AI・IoT related to healthcare
- InnoVeinY Combinator W16
We cure intractable leg wounds with a replacement valve for veins.
- Lucira HealthY Combinator W15
Next generation infectious disease test kits
- 株式会社スカイライト・バイオテックPlug and Play
Skylight Biotech provides solutions for research, prevention and diagnosis in lifestyle-related diseases.
- mFluiDXSOSV SOSV IndieBio 03
Enabling molecular detection anywhere
- HepatxY Combinator S18
Replacing organ transplant with an infusion